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Cytochrome c oxidase, the terminal enzyme of the
respiratory chain, is assembled from mitochondria-
and nuclear-encoded subunits. The MITRAC com-
plex represents the central assembly intermediate
during this process as it receives imported subunits
and regulates mitochondrial translation of COX1
mRNA. The molecular processes that promote and
regulate the progression of assembly downstream
of MITRAC are still unknown. Here, we identify
MITRAC7 as a constituent of a late form of MITRAC
and as a COX1-specific chaperone. MITRAC7 is
required for cytochrome c oxidase biogenesis. Sur-
prisingly, loss of MITRAC7 or an increase in its
amount causes selective cytochrome c oxidase
deficiency in human cells. We demonstrate that
increased MITRAC7 levels stabilize and trap COX1
in MITRAC, blocking progression in the assembly
process. In contrast, MITRAC7 deficiency leads to
turnover of newly synthesized COX1. Accordingly,
MITRAC7 affects the biogenesis pathway by stabiliz-
ing newly synthesized COX1 in assembly intermedi-
ates, concomitantly preventing turnover.
INTRODUCTION
Mitochondrial oxidative phosphorylation provides the majority of
ATP required to sustain the energetic requirements of eukaryotic
cells. The respiratory chain complexes generate the proton
gradient that drives the F1Fo ATP-synthase that produces ATP
from ADP and Pi. There are 13 core subunits of the oxidative
phosphorylation system that are encoded within mtDNA and
translated by membrane-associated ribosomes (Chacinska
et al., 2009; Ha¨llberg and Larsson, 2014; Mick et al., 2011; Ott1644 Cell Reports 12, 1644–1655, September 8, 2015 ª2015 The Auand Herrmann, 2010). To form functional enzyme complexes,
mitochondrial-encoded proteins associate with imported nu-
clear-encoded subunits in the inner mitochondrial membrane.
This assembly process is highly regulated and a plethora of
so-called assembly factors are required to stabilize maturing in-
termediates in the inner membrane, or to catalyze the insertion of
cofactors, which are essential for the functionality of the com-
plexes (Carr and Winge, 2003). However, for none of the known
assembly factors, except for some enzymes involved in cofactor
maturation, a molecular function or mechanism of action has
been defined. Nevertheless, these assembly factors have been
instrumental for defining distinct stages of the biogenesis pro-
cess as well as regulatory processes. Malfunction of many of
these assembly factors and the concomitant defects in the as-
sembly process have been linked to severe human disorders
that usually affect tissues with high energy demands, such as
neurons, skeletal, and cardiac muscle (Bourens et al., 2013;
Ghezzi and Zeviani, 2012; Shoubridge, 2001). While a loss of
function of structural subunits can affect biogenesis of a given
complex, the lack of an assembly factor can lead to a block in
enzymematuration. Concomitantly, intermediates of the assem-
bly process have been frequently found to accumulate in pa-
tients with mitochondrial disorders (Ghezzi and Zeviani, 2012;
Smeitink et al., 2006). While on the one hand a lack or reduction
of any functional enzyme complex affects the overall perfor-
mance of oxidative phosphorylation with systemic conse-
quences for cellular metabolism, the accumulation of assembly
intermediates may exacerbate the effect on the cell through
the production of reactive oxygen species (Khalimonchuk
et al., 2007; Shoubridge, 2001; Smeitink et al., 2006; Tatsuta
and Langer, 2008). Hence, eukaryotic cells need to provide
mechanisms that control respiratory chain biogenesis and pro-
tect mitochondria from damaging assembly intermediates.
In the case of cytochrome c oxidase (complex IV), the three
core components, COX1, COX2, and COX3, are mitochondria-
encoded. COX1 represents the nucleus for the biogenesis pro-
cess to which imported subunits as well as COX2 and COX3,thors
associate in a sequential manner. In yeast mitochondria, transla-
tion of COX1 mRNA depends on specific translational activator
proteins that interact with its 50UTR (Barrientos et al., 2009; Ha¨ll-
berg and Larsson, 2014; Mick et al., 2012; Soto et al., 2012). The
newly synthesized Cox1 protein engages with the early assem-
bly factors Coa3 and Cox14 in the inner membrane of mitochon-
dria, which stabilize the protein. Under conditions in which
assembly of Cox1 becomes stalled, translation of COX1 mRNA
is shut down through inactivation of the translation-activator
Mss51 (Barrientos et al., 2009; Mick et al., 2011; Soto et al.,
2012). This feedback inhibition is thought to prevent an accumu-
lation of assembly intermediates at the start of the biogenesis
process (Barrientos et al., 2009; Mick et al., 2011). Similar trans-
lation regulating mechanisms have been found for COB1mRNA
of the bc1 complex (Hildenbeutel et al., 2014).
In contrast to yeast, humanmitochondrial mRNAs lack 50UTRs
and functional homologs of the translation activators have not
been identified. However, a regulatory cycle that links COX1 as-
sembly to the translation of its mRNA is also present in human
mitochondria, as suggested by several studies (Clemente
et al., 2013; Mick et al., 2012; Szklarczyk et al., 2012; Weraarpa-
chai et al., 2012). The newly synthesized COX1 protein rapidly in-
corporates into a multi-subunit assembly intermediate in the
inner membrane termed mitochondrial translation regulation as-
sembly intermediate of cytochrome c oxidase (MITRAC) com-
plex. The two core components of MITRAC are MITRAC12
(COA3) and C12ORF62 (COX14). A lack of these proteins leads
to cytochrome c oxidase deficiency and reduced COX1 transla-
tion (Mick et al., 2012; Ostergaard et al., 2015; Weraarpachai
et al., 2012). Thus, at the early stage of cytochrome c oxidase
biogenesis, a control mechanism is in place that allows mito-
chondria to adapt the synthesis of COX1 to cellular demands.
However, the molecular mechanisms underlying this process
are still unknown and it is clear that they will be significantly
different from the processes in yeast.
The MITRAC complex receives early-assembling imported
subunits of cytochrome c oxidase from the mitochondrial prese-
quence translocase (Mick et al., 2012). This process requires the
TIM21 protein, which shuttles between the TIM23 complex and
MITRAC to deliver the imported subunits. Hence, the MITRAC
complex in fact represents several crucial stages of distinct
COX1 assembly intermediates during the early steps of cyto-
chrome c oxidase biogenesis. Accordingly, COX1 biogenesis
through MITRAC is a dynamic process. However, the distinct
stages of thisMITRAC-associated process remain to be defined.
Here, we report on the identification and functional analysis of
MITRAC7. MITRAC7 represents an uncharacterized subunit of
MITRAC that acts in the biogenesis pathway downstream
of the translation feedback stage. Our analyses show that
MITRAC7 is required for cytochrome c oxidase biogenesis.
MITRAC7 promotes the progression of COX1 assembly after
TIM21-dependent incorporation of the early subunit COX4-1.
Our analyses suggest a second checkpoint in cytochrome c
oxidase assembly downstream of COX1 translation regulation.
While increased levels of MITRAC7 block COX1 assembly,
stabilizing it as a late MITRAC intermediate, loss of MITRAC7
leads to turnover of COX1. We conclude that mitochondria
monitor respiratory chain biogenesis to initiate stage-specificCell Reprotectivemechanismsduring cytochromecoxidasebiogenesis.
MITRAC7 is a chaperone-like assembly factor required to stabi-
lize newly synthesized COX1 to prevent its premature turnover.
RESULTS
MITRAC7 Associates with MITRAC12 in the Inner
Mitochondrial Membrane
TheMITRAC complex represents a platform for the early steps of
cytochrome c oxidase assembly, integrating the biogenesis of
mitochondrial-derived COX1 with that of imported nuclear-en-
coded subunits. To identify and functionally define cytochrome
c oxidase assembly factors in humanmitochondria, we analyzed
proteins in affinity purified MITRAC12-containing complexes by
quantitative mass spectrometry using stable isotope labeling
by amino acids in cell culture (SILAC) (Mick et al., 2012). Since as-
sembly factors often represent small membrane proteins, we
focused onproteinswith a lowmolecular weight. Amongproteins
that copurified specifically with MITRAC12FLAG and displayed
significant enrichment based on SILAC ratios, we identified the
uncharacterizedC4ORF52protein thatwe later termedMITRAC7
(Figure 1A). Sequence similarity searches did not reveal potential
homologs in lower eukaryotes. However, MITRAC7 is highly
conserved in metazoa (Figure S1). MITRAC7 displays a single
predicted transmembrane span, but lacks a predictable N-termi-
nal presequence for translocation across the inner mitochondrial
membrane (Figure 1B). To confirm the mitochondrial localization
ofMITRAC7,we transfectedU2OScellswith aMITRAC7FLAG-ex-
pressing plasmid. MITRAC7 was detected with monoclonal anti-
FLAG antibodies and mitochondrial networks were visualized
with MitoTracker red. Diffraction-limited confocal microscopy
was performed and superimposition of green and red signals
supports the mitochondrial localization of MITRAC7 (Figure 1C).
To assess processing and import, we synthesized [35S]
MITRAC7 in reticulocyte lysate. MITRAC7 could be imported
into isolatedmitochondria in a time-dependentmanner to a prote-
ase-protected location. However, no processing of the imported
protein was observed, supporting the prediction that it is not
directed into mitochondria by a cleavable presequence (Fig-
ure 1D). Interestingly, a fraction of MITRAC7 was imported under
conditions in which the membrane potential (Dc) had been dissi-
pated. In contrast, radiolabeled ornithine-transcarbamylase
([35S]OTC)was imported inaDc-dependentmanneracross the in-
nermembrane (Figure 1D). The fact that smallmembrane proteins
frequently display only limited dependency onDc is in agreement
with previous findings (Mick et al., 2012; Wagner et al., 2009).
To address the submitochondrial localization of MITRAC7, we
performed hypo-osmotic swelling and carbonate extraction ex-
periments. The recovery of MITRAC7 in each sample was deter-
mined by western blot analysis using an antiserum directed
against the C terminus of the protein. MITRAC7 was present in
isolated mitochondria and only became accessible to protease
treatment when the outer membrane was disrupted (Figure 1E).
SinceMITRAC7was resistant to carbonate extraction (Figure 1F),
we conclude that MITRAC7 is an inner mitochondrial membrane
proteinwith itsC terminus facing the intermembrane space (IMS).
To confirm the association between MITRAC12 and
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Figure 1. MITRAC7 Is a Mitochondrial Protein Associated with MITRAC
(A) Identification of MITRAC7. Sections of mass spectra of selected SILAC peptide pairs fromMITRAC12 (bait), MITRAC7 (prey), and GAPDH (control) are shown.
(B) Deduced primary sequence of MITRAC7. The predicted transmembrane spans (TM) and protein organization (numbers indicate amino acid residues) are
shown.
(legend continued on next page)
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immunoprecipitation fromdigitonin solubilizedmitochondria, us-
ing an antiserum directed against the C terminus of MITRAC12.
Established MITRAC components, such as COX1 and SURF1,
as well as MITRAC7, were efficiently copurified with MITRAC12
(Figure 1G). Thus, we conclude that MITRAC7 represents a MI-
TRAC12-associated protein in the inner mitochondrial
membrane.
MITRAC7 Interacts with Newly Synthesized COX1
To further investigate the association of MITRAC7 with cyto-
chrome c oxidase assembly intermediates, we generated a sta-
ble cell line expressingMITRAC7with a C-terminal FLAG-tag un-
der control of an inducible promoter. Mitochondria from this cell
line were isolated and subjected to immunoprecipitation experi-
ments. For comparison, MITRAC12FLAG was immunoprecipi-
tated from a corresponding cell line (Mick et al., 2012). Both pro-
teins were efficiently precipitated from detergent extracts and
COX1 copurified in both samples. MITRAC12 was detected in
the MITRAC7FLAG elution, whereas subunits of complex III, com-
plex I, and the TIM23 complex were not recovered (Figure 2A).
The copurification of COX1withMITRAC7FLAG prompted us to
address whether MITRAC7 associates with newly synthesized
COX1. Therefore, we radiolabeled mitochondrial translation
products prior to the isolation of MITRAC12FLAG- and
MITRAC7FLAG-containing complexes. Similar to MITRAC12,
newly synthesized COX1 was preferentially coisolated with
MITRAC7 (Figure 2B). When samples were eluted under native
conditions and subjected to separation by blue native (BN)-
PAGE, complexes containing radiolabeled mitochondrial COX1
were visualized by digital autoradiography. As previously re-
ported, isolation of MITRAC12FLAG enriched the COX1-contain-
ing MITRAC complex (Mick et al., 2012) and a complex of similar
size was detected in the MITRAC7FLAG elution. However,
compared to MITRAC12FLAG, COX1was also present in a slower
migrating form of the MITRAC complex upon isolation with
MITRAC7FLAG (Figure 2C, lane 6). These observations demon-
strate that MITRAC7 is a component of the MITRAC complex
during early steps of COX1 assembly.
To investigate whether MITRAC7 directly interacts with COX1,
we carried out crosslinking experiments. Therefore, mitochon-
dria containing MITRAC7FLAG were subjected to BS2-d0-medi-
ated chemical crosslinking prior to MITRAC7FLAG immunopre-
cipitation. As expected, a crosslink between MITRAC7 and
COX1 was specifically recovered in immunoprecipitations from
BS2-d0-treated samples, but not from the control (Figure 2D).
Hence, we conclude that MITRAC7 directly contacts COX1.
To this end, we wanted to determine at which stage MITRAC7
participates in the assembly process and if MITRAC7 is present
in MITRAC after incorporation of the first nuclear-encoded sub-
units. Therefore, we imported [35S]COX4-1, an early-assembling(C) Immunofluorescencemicroscopy of U2OS cells expressingMITRAC7FLAG usin
5 mm).
(D) [35S]MITRAC7 and [35S]OTCwere imported into isolated mitochondria in the pr
PK, subjected to SDS-PAGE, and analyzed by digital autoradiography (precurso
(E) Submitochondrial localization of MITRAC7 analyzed by protease protection
mitochondria, MP), or to sonicated mitochondria (Sonic.).
(F) Membrane association of MITRAC7. The mitochondria were subjected to car
(G) Immunoprecipitation using MITRAC12 and control antisera (aIgGcon) (Total, 1
Cell Resubunit of cytochrome c oxidase, into MITRAC7FLAG-containing
mitochondria. As expected, [35S]COX4-1 coisolated with
MITRAC7FLAG, indicating an association of MITRAC7 with early
cytochrome c oxidase assembly intermediates (Figure 2E). This
interpretation was further supported when isolations of
MITRAC7FLAG were analyzed by BN-PAGE. The [35S]COX4-1-
containing complexes migrated like the MITRAC complex, in
the range of 200 kDa, and thus below the mature oxidase (Fig-
ure 2F). In agreement with this, when [35S]MITRAC7 was im-
ported into MITRAC12FLAG-containing mitochondria prior to
the isolation of MITRAC12FLAG-containing complexes,
[35S]MITRAC7 was solely recovered in the MITRAC complex
and not in mature cytochrome c oxidase. In contrast, in the
same isolation, COX1 was detected with the MITRAC-complex
and the mature cytochrome c oxidase (Figure 2G).
Interaction of MITRAC7 with COX1 Depends on
Integration of Nuclear-Encoded Subunits into MITRAC
Our analyses indicated that the MITRAC complex represents a
population of COX1-containing complexes, which differ to
some extent in their protein composition (Mick et al., 2012; Fig-
ure 2C). Among these complexes, MITRAC7 appears to be pre-
sent in a slower migrating form of MITRAC compared with
MITRAC12. This interpretation was corroborated when mito-
chondrial protein complexes were separated in a first-dimension
by BN-PAGE and subsequently subjected to 2D separation by
SDS-PAGE (Figure S2A). MITRAC7 clearly comigrated with the
MITRAC complex as expected, based on the previous experi-
ments (see Figure 2C). However, the majority of MITRAC7 was
present in the slower migrating MITRAC-form (Figure S2A).
Hence, we asked at which stage of the assembly process
MITRAC7 acts. After initial association of COX1 with MITRAC12
and C12ORF62, nuclear-encoded cytochrome c oxidase sub-
units are integrated into MITRAC through TIM21. To assess
whether MITRAC7 and TIM21 are present in MITRAC complexes
simultaneously, we isolated complexes via MITRAC12FLAG and
MITRAC7FLAG. While MITRAC12FLAG efficiently coisolated
TIM21, only low amounts of TIM21were present inMITRAC7FLAG
samples (Figure 3A). Moreover, when MITRAC12FLAG-,
MITRAC7FLAG-, or TIM21FLAG-containing complexes were puri-
fied after radiolabelling of mitochondrial translation products
and separation by BN-PAGE, different sets of complexes were
apparent. MITRAC7FLAG enriched two distinct COX1-containing
complexes. Interestingly, TIM21FLAG purified a complex that mi-
grates between the two complexes apparent in the MITRAC7-
FLAG sample (Figure 3B). Thus, we conclude that MITRAC7 is a
constituent of complexes largely devoid of TIM21.
To address whether MITRAC7 acts prior to the insertion of nu-
clear-encoded proteins, or downstream of TIM21, we analyzed if
the interaction of MITRAC12 or TIM21 with COX1 depends ong anti-FLAG antibodies and staining withMitoTracker red (scale bar represents
esence or absence of membrane potential (Dc). The samples were treated with
r, p; mature protein, m).
. PK was applied to mitochondria (Mito.), mitoplasts (hypotonically swollen
bonate extraction or detergent lysis (total, T; pellet, P; and soluble faction, S).
% and Eluate, 100%).
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Figure 2. MITRAC7 Is a Constituent of the
MITRAC Complex
(A) Immunoprecipitation from wild-type,
MITRAC12FLAG-, and MITRAC7FLAG-containing
mitochondria (Total, 1% and Eluate, 100%).
(B and C) Immunoprecipitation from whole cells as
described in Figure 1A after 1 hr labeling of mito-
chondrial translation products with [35S]methio-
nine. The samples were analyzed by SDS- (B) or
BN-PAGE (C) and digital autoradiography (Total,
2.5% and Eluate, 100%).
(D) MITRAC7FLAG-containing mitochondria were
treated with BS2-d0 crosslinker or left untreated
and subjected to denaturing immunoprecipita-
tions. The eluates were split and subjected to SDS-
PAGE followed by western blotting (Total, 2% and
Eluate, 100%, asterisk indicates unspecific signal).
(E) [35S]COX4-1 was imported into mitochondria
from wild-type or MITRAC7FLAG-expressing cells.
After import, immunoprecipitation was performed
as in Figure 2A and samples were analyzed by
SDS-PAGE and digital autoradiography (Total, 2%
and Eluate, 100%); (precursor, p; mature, m)
(F) Import of [35S]COX4-1 into isolated mito-
chondria containing MITRAC7FLAG, followed by
anti-FLAG immunoprecipitation under native con-
ditions. The sampleswere separatedeither bySDS-
(bottom) or BN-PAGE (top) and visualized by digital
autoradiography (Total, 2% and Eluate, 100%).
(G) [35S]MITRAC7 was imported into isolated mito-
chondria from MITRAC12FLAG-containing cells and
the experiment performed as in Figure 2E. The
elution was split for BN-PAGE (60% for digital
autoradiography, top left and 30% for western
blotting, top right) and SDS-PAGE (10%, bottom)
(complex VI, VI) (Total, 2%).the presence of MITRAC7. Thus, we assessed the binding of
MITRAC12 or TIM21 to newly synthesized COX1 in MITRAC7-
depleted cells (see also Figure 4). Mitochondrial translation
products were pulse labeled in MITRAC7 depleted cells and
TIM21FLAG- or MITRAC12FLAG-containing complexes were puri-
fied. The association of newly synthesized COX1with TIM21FLAG
and MITRAC12FLAG (Figures 3C and 3D) remained unaltered,
demonstrating that the interactions of TIM21 and MITRAC12
with newly synthesized COX1 occur independent of MITRAC7.
Based on this observation and the migration of MITRAC7 in a
large MITRAC-complex, we hypothesized that MITRAC7 acts at
a later stage of COX1 assembly rather than at the step of TIM21-
dependent insertion of nuclear-encoded subunits. To test this
directly, we established immunoprecipiation conditions for the
endogenous MITRAC12 and MITRAC7 proteins. After radiolab-
elling of mitochondrial translation products, proteins copurifying
with MITRAC12 and MITRAC7 were separated by SDS-PAGE.1648 Cell Reports 12, 1644–1655, September 8, 2015 ª2015 The AuthorsAmong the mitochondrial-encoded pro-
teins, COX1 was specifically enriched in
MITRAC12 and MITRAC7 eluates (Fig-
ure 3E, left). This result is consistent with
our previous analyses using the FLAG-
tagged proteins (see Figure 2A). Western
blot analyses showed that MITRAC12and MITRAC7 were enriched in the eluates, coisolated each
other efficiently, but did not immunoprecipitate abundant mito-
chondrial proteins such as the RIESKE Fe/S protein (Figure 3E,
right).
Hence, we addressed the association of newly synthesized
COX1 with MITRAC12 and MITRAC7 in the absence of TIM21.
In general, TIM21-depleted cells displayed a subtle increase in
the translation of all mitochondrial-encoded proteins (Figures
S2B and S2C). While a lack of TIM21 did not affect the associa-
tion of MITRAC12 with COX1 (Figures 3F and S2B), we observed
a significant reduction in the amount of COX1 coisolating with
MITRAC7 (Figures 3F and S2C). This finding prompted us to
investigate whether the interaction of MITRAC7 with newly syn-
thesized COX1 depends on the integration of early-assembling
nuclear-encoded cytochrome c oxidase subunits. Therefore,
we depleted COX4-1 and COX6C. Both proteins were efficiently
reduced after small interfering (si)RNA treatment (Figures S2D
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Figure 3. COX1-MITRAC7 Interaction Depends on Incorporation of Nuclear-Encoded COX-Subunits
(A) Mitochondria from wild-type, MITRAC12FLAG-, and MITRAC7FLAG-expressing cells were solubilized and subjected to anti-FLAG immunoprecipitation. The
eluates were analyzed by SDS-PAGE and western blotting (Total, 1% and Eluate, 100%).
(B)Mitochondrial translation products were radiolabeled in wild-type,MITRAC12FLAG-, andMITRAC7FLAG-expressing cells. The anti-FLAG immunoprecipitations
were performed as described in (A) and samples were analyzed by BN-PAGE and digital autoradiography (Total, 10% and Eluate, 100%).
(C and D) TIM21FLAG- (C) or MITRAC12FLAG- (D) expressing cells were treated with MITRAC7-specific or non-targeting (NT) control siRNA for 72 hr. After [35S]
methionine labeling of mitochondrial translation products, the whole cell lysates were subjected to anti-FLAG immunoprecipitation. The eluates were analyzed by
SDS-PAGE and digital autoradiography (Total, 2% and Eluate, 100%)
(E) Antibodies against MITRAC12, MITRAC7, or control antisera (aIgGcon) were used for immunoisolation after [35S]methionine labeling of mitochondrial
translation products and analyzed by SDS-PAGE and digital autoradiography (Total, 7% and Eluate, 100%).
(F) Quantification of isolated COX1 from immunoprecipitations with anti-MITRAC12 or anti-MITRAC7 antibodies after TIM21, COX4-1, or COX6C depletion (mean
± SEM and n = 3).and S2E). Upon COX4-1 and COX6C knockdown, the interaction
of MITRAC7 with newly synthesized COX1 was significantly
reduced. In contrast, the association of MITRAC12 with COX1
was only marginally affected (Figure 3F). In conclusion, the asso-
ciation of newly synthesized COX1 with MITRAC7 depends on
the TIM21-mediated incorporation of nuclear-encoded subunits
into MITRAC.
MITRAC7 Is Required for Cytochrome c Oxidase
Assembly
To assess the function of MITRAC7, we generated two different
siRNAs targeting MITRAC7 and transfected these into human
embryonic kidney cell lines (HEK)293T cells. Reduction of
MITRAC7 levels resulted in a severe growth phenotype
compared to the non-targeting control (Figure 4A). To excludeCell Reoff-target effects, we created a stable HEK293T-cell line ex-
pressing an siRNA1-resistant MITRAC7FLAG transcript, encod-
ing scMITRAC7FLAG. Induction of scMITRAC7FLAG fully rescued
the growth phenotype after siRNA application (Figure 4B)
despite the fact that scMITRAC7FLAG was slightly less abundant
than the endogenous MITRAC7 protein (Figure 4C). These re-
sults verified the specific targeting of MITRAC7 by siRNA1 and
the functionality of the MITRAC7FLAG construct. Since MITRAC7
and MITRAC12 are present in the same complex, we investi-
gated the interdependence of both proteins by performing pro-
tein steady-state level analysis after depletion experiments.
The stability of both proteins did not depend on the presence
of the other protein (Figures S3A and S3B).
Next, we investigated the effect of MITRAC7 knockdown on
cytochrome c oxidase biogenesis. Therefore, we analyzedports 12, 1644–1655, September 8, 2015 ª2015 The Authors 1649
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Figure 4. MITRAC7 Is Required for Cyto-
chrome c Oxidase Biogenesis
(A) HEK293T cells were transfected with siRNAs
against MITRAC7 or non-targeting (NT) control
siRNA as indicated. The cells were grown for 72 hr
and counted after harvesting (dotted-line marks
starting amount of cells; 1.25 3 104) (mean ± SEM
and n = 6).
(B and C) Wild-type HEK293T cells or cells ex-
pressing the siRNA-resistant scMITRAC7FLAG
were transfected, cultured, and counted as in
Figure 4A (dotted-line marks starting amount of
cells; 1.25 3 104) (mean ± SEM and n = 6) and
further analyzed by SDS-PAGE and western blot-
ting (C).
(D) Isolated mitochondria from cells treated with
MITRAC7 siRNA1 as in Figure 4Awere analyzed by
BN-PAGE and in-gel activity assays for complexes
I, II, IV, and V.
(E) Measurement of enzyme activity (left) and
relative amount of cytochrome c oxidase (right); the
siRNA treatment was performed as described in (A)
(mean ± SEM and n = 6).respiratory chain complexes after solubilization by BN-PAGE
and performed in-gel activity staining for complexes I, II, IV,
and V. While the activities of complex I, II, and V were not
decreased upon knock down of MITRAC7, complex IV activ-
ity was drastically reduced (Figure 4D). For a quantitative
assessment, we measured cytochrome c oxidase activity
and quantified the amount of enzyme by ELISA. In MITRAC7
knockdown cells, the cytochrome c oxidase activity was
reduced to 65% compared to the non-targeting siRNA con-
trol (Figure 4E, left). This reduction in activity was fully ex-
plained by a drastic reduction of complex IV to 45%, as
compared to the control (Figure 4E, right). Accordingly, loss
of MITRAC7 in HEK293T cells leads to a loss of cytochrome
c oxidase.
Increasing MITRAC7 Levels Affect Cytochrome c
Oxidase Biogenesis
Given that loss of MITRAC7 resulted in complex IV deficiency,
we sought to investigate the phenotype of MITRAC7 overex-
pressing cells. To this end, MITRAC7FLAG was expressed at a
10-fold higher amount compared with the endogenous MI-
TRAC7 level (Figure 5A). Cells with increased MITRAC7FLAG
levels displayed a clear growth phenotype at the tested time
points (Figure 5A). To study the amount and activity of cyto-
chrome c oxidase in mitochondria isolated from cells overex-
pressing MITRAC7FLAG, compared with control cells, we1650 Cell Reports 12, 1644–1655, September 8, 2015 ª2015 The Authorsperformed in-gel activity assays. The ac-
tivities of complex I and the F1Fo ATP-syn-
thase were not affected by MITRAC7FLAG
overexpression, but a subtle increase in
complex II activity was detected. How-
ever, a drastic reduction of cytochrome c
oxidase activity was apparent (Fig-
ure 5B). Given that in-gel activity staining
is not quantitative, we overexpressedMITRAC7FLAG and quantified the activity and amount of cyto-
chrome c oxidase in cell extracts. Cytochrome c oxidase activity
was severely reduced after 1 day of MITRAC7FLAG induction and
decreased even further after 3 days (Figure 5C, left). Similarly,
the amount of complex IV was reduced compared to the control
(Figure 5C, right), thereby explaining the reduction in cytochrome
c oxidase activity. Thus, we conclude that a tightly balanced level
of MITRAC7 is critical for cytochrome c oxidase assembly.
Reduced, as well as increased, amounts of MITRAC7 impact
the biogenesis of the enzyme complex.
Loss of MITRAC7 Destabilizes COX1 in Mitochondria
Defects or loss of the MITRAC complex constituents C12ORF62
or MITRAC12 selectively affect COX1 translation (Mick et al.,
2012; Ostergaard et al., 2015; Weraarpachai et al., 2012). As
MITRAC7 similarly binds newly synthesized COX1, we analyzed
mitochondrial protein synthesis in cells overexpressing
MITRAC7FLAG or in which MITRAC7 levels were reduced by
siRNA-mediated knockdown. Upon MITRAC7FLAG overexpres-
sion, a reduction in the amount of newly synthesized COX1
was apparent when mitochondrial translation products were
pulsed labeled with [35S]methionine (Figure 6A). In contrast, sub-
units of other complexes were not affected, e.g., ND1/ND2.
Quantifications confirmed these significantly reduced COX1
levels upon MITRAC7FLAG overexpression (Figure 6A, right). In
contrast, after [35S]methionine pulse labeling, MITRAC7
Figure 5. Cytochrome cOxidase Biogenesis
Is Affected by Increased MITRAC7 Levels
(A) HEK293T cells were counted after indicated
induction times (ind/h) of MITRAC7FLAG or an un-
related control mitochondrial protein (top, mean ±
SEM and n = 6) or analyzed by SDS-PAGE and
western blotting (bottom).
(B) In-gel activity assays for complexes I, II, IV, and
V after mitochondria isolation from cells induced
for expression of MITRAC7FLAG or a control
protein.
(C) Quantification of cytochrome c oxidase activity
(right) and amount (left) as in Figure 4E after over-
expression of MITRAC7 (mean ± SEM and n = 6).depleted cells did not display a significant change in the amount
of mitochondrial-encoded proteins (Figure 6B).
This experiment did not provide an explanation as to why
MITRAC7 overexpression and knockdown similarly lead to cy-
tochrome c oxidase deficiency. Therefore, we carried out pulse
chase analyses to follow the fate of newly synthesized COX1
over the course of 12 hr. This time frame is usually sufficient
for newly synthesized COX1 to be incorporated into the mature
complex. Despite the reduced amount of COX1 observed un-
der conditions of a short pulse (Figure 6A), in an extended
chase, the newly synthesized COX1 accumulated over time
when MITRAC7 was overexpressed (Figures 6C and S3C). In
contrast, ND1/ND2 did not display significant changes in their
amount. Surprisingly, in MITRAC7 depleted cells, that dis-
played no difference to the wild-type with regard to COX1
upon pulse labeling (Figure 6B), we observed less COX1 than
in the control in an extended chase analysis, indicative of
decreased COX1 stability. At the same time ND1/ND2 did not
display significant changes in their stability (Figures 6C and
S3D). Accordingly, although both loss of MITRAC7 and its over-
production caused cytochrome c oxidase deficiency, we
observed opposing effects on the stability of newly synthesized
COX1 in mitochondria. While an increased turnover of COX1
explains the defect in cytochrome c oxidase biogenesis for
the knockdown condition, the increased stability of COX1 inCell Reports 12, 1644–1655, SeMITRAC7 overexpressing cells could still
not be directly linked to a loss of the cy-
tochrome c oxidase.
We hypothesized that the newly syn-
thesized COX1, which accumulates
upon MITRAC7 overexpression, reflects
an arrest of COX1 assembly at the level
of MITRAC. To address this hypothesis,
we labeled mitochondrial translation
products in vivo and analyzed COX1-
containing complexes after an extended
chase. Complexes were separated in a
first dimension by BN-PAGE and subse-
quently subjected to a 2D separation by
SDS-PAGE. For comparison, we de-
tected selected MITRAC components
by western-blotting after digital autoradi-ography visualization of the [35S]methionine-labeled protein
(Figure 6D). As demonstrated by MITRAC12 and MITRAC7
detection, the MITRAC complex, in the control, migrated be-
tween 230 kDa and 400 kDa, whereas MITRAC7 overexpres-
sion resulted in a shift of MITRAC7 and MITRAC12 to a slower
migrating form of the complex. Clearly, newly synthesized
COX1 accumulated in MITRAC of mitochondria with increased
MITRAC7 levels and COX1 did not assemble into mature cyto-
chrome c oxidase compared to control cells (Figure 6D). This
observation is in agreement with the presence of MITRAC7 in
slower migrating MITRAC complexes and explains the
increased COX1 stability upon MTRAC7FLAG overexpression.
To address the presence of newly synthesized COX1 in
MITRAC directly, we immunoprecipitated MITRAC12 after
pulse chase labeling of mitochondrial-encoded proteins in
MITRAC7 overexpressing and control cells. Eluates were sub-
jected to SDS-PAGE and copurified, radiolabeled proteins
were visualized by digital autoradiography (Figure 6E). The coi-
solation of newly synthesized COX1 with MITRAC12 was dras-
tically increased when MITRAC7 was overexpressed (Fig-
ure 6E). Hence, an increase in the amount of MITRAC7 leads
to COX1 accumulation in MITRAC. Taken together, with the
observed lack of mature cytochrome c oxidase, we conclude
that increased levels of MITRAC7 stall COX1 during the assem-
bly process.ptember 8, 2015 ª2015 The Authors 1651
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Figure 6. MITRAC7 Stabilizes Newly Synthesized COX1
(A) After 72 hr of MITRAC7FLAG induction in HEK293T cells, mitochondrial translation products were [35S]methionine pulse labeled for 1 hr. The cell extracts were
subjected to SDS-PAGE followed by western blotting and were analyzed by digital autoradiography (left). The values represent quantifications of the indicated
mitochondrial translation products normalized to ATP6 (mean ± SEM and n = 3).
(B) Labeling of mitochondrial translation products after siRNAmediated MITRAC7 depletion. The cell extracts were subjected to SDS-PAGE followed by western
blotting and digital autoradiography.
(C) [35S]methionine labeling of mitochondrial translation products as in Figures 6A and 6B. Subsequently, the medium was replaced and cells were further
cultured in standard medium (chase; 12 hr). The cell extracts were analyzed by SDS-PAGE (Figures S3C and S3D). The values represented were normalized to
ATP6 (mean ± SEM and n = 3).
(D) Pulse chase [35S]methionine-labeling of mitochondrial translation products after MITRAC7FLAG overexpression as described in Figure 6C. The proteins from
whole cells were isolated under non-denaturing conditions and complexes were separated by BN-PAGE, followed by a second dimension SDS-PAGE and
western blot analysis. The proteins were detected by digital autoradiography (COX1) or by using indicated antibodies (complex IV, IV).
(E) [35S]methionine labeling of mitochondrial translation products (pulse) followed by chase after MITRAC7FLAG expression as described in Figure 6D. The whole
cell extracts were subjected to immunoprecipitation using anti-MITRAC12 or control antiserum (aIgGcon). The eluates were analyzed by digital autoradiography
after SDS-PAGE (Total, 5% and Eluate, 100%) and quantified using ImageQuant software.DISCUSSION
The MITRAC complex defines an early stage in assembly of the
cytochrome c oxidase (Clemente et al., 2013; Mick et al., 2012;
Ostergaard et al., 2015; Peralta et al., 2012; Szklarczyk et al.,
2012;Weraarpachai et al., 2012). MITRAC receives early-assem-
bling nuclear-encoded subunits, which are imported into mito-
chondria along the presequence import pathway. At the same
time, MITRAC constituents have been implicated in the regula-
tion of COX1 translation on mitochondrial ribosomes, but may
at the same time contribute to the stabilization of the newly syn-
thesized COX1 protein. It is conceivable that both of these func-
tions are tightly linked. A translational regulation byMITRAC con-1652 Cell Reports 12, 1644–1655, September 8, 2015 ª2015 The Austituents plays an important role for the fidelity of the assembly
process (Mick et al., 2012; Weraarpachai et al., 2012). Upon an
early block in assembly and the concomitant accumulation of
COX1, the supply of newly synthesized COX1 is stalled to pre-
vent further accumulation of MITRAC complexes. Accordingly,
this stage of translational regulation represents an early regulato-
ry step in cytochrome c oxidase assembly, adapting COX1 avail-
ability to the influx of early-assembling imported subunits. More-
over, this regulatory stage allows cells to provide a readily
available pool of COX1 in the inner membrane as a seed for as-
sembly. While in yeast mitochondria a translational feedback
mechanism for Cox1 expression is mediated by mRNA-specific
translation activators, the molecular details of the feedbackthors
regulation process in metazoa are only beginning to be
approachable through the identification of MITRAC12 and
C12ORF62 (for review see Soto et al., 2012; Dennerlein and Re-
hling, 2015). An experimental challenge in defining proteins that
participate in translation regulation is the fact that a loss of COX1
can be due to reduced synthesis, as well as to an increased turn-
over. Hence, detailed experimental analyses are required to
differentiate between these two possibilities. However, obvi-
ously translation regulation in yeast and metazoan have to be
mechanistically very different. In yeast coa3D and cox14D mu-
tants the half time of Cox1 is in the range of a few minutes, while
the synthesis of Cox1 is increased by several-fold through hyper-
activation of Mss51. Hence, Coa3 and Cox14 do not affect
translation directly, but do so indirectly through the translational
activator Mss51 (for review see Mick et al., 2011). Despite
low sequence similarity between these yeast proteins and
MITRAC12 and C12ORF62, respectively, the human proteins
fulfill opposite function in human mitochondria (Mick et al.,
2012; Ostergaard et al., 2015; Weraarpachai et al., 2012).
We find that MITRAC represents a population of complexes
that are ill defined in composition and function. Our analyses
identify MITRAC7 as a so far uncharacterized constituent of a
late MITRAC complex. MITRAC7 is required for assembly of cy-
tochrome c oxidase. Interestingly, by unbalancing MITRAC7
availability inmitochondria, the assembly process of cytochrome
c oxidase is affected in different ways. While a loss of MITRAC7
leads to turn over of COX1, overabundance of MITRAC7 stalls
assembly and stabilizes newly synthesized COX1. Under both
conditions, the translation of COX1 mRNA remains unaffected,
indicating that the stage of the assembly process at which
MITRAC7 acts has passed beyond the stage of translational
feedback regulation of COX1. Our findings reveal a checkpoint
in the assembly pathway of COX1. Lack of MITRAC7 is accom-
panied by proteolytic removal of COX1. The degradation of
COX1-containing assembly intermediates upon loss of an as-
sembly factor is not a general phenomenon that occurs at every
stage of an improper cytochrome c oxidase biogenesis process.
In fact, a number of patients with mutations in cytochrome c ox-
idase assembly factors have been found to accumulate interme-
diates of the assembly pathway, while others do not display sig-
nificant amounts of immature complexes (Antonicka et al.,
2003a, 2003b; Bourens et al., 2014; Ghezzi and Zeviani, 2012;
Huigsloot et al., 2011; Leary et al., 2004; Lim et al., 2014; Ola´hova´
et al., 2015; Ostergaard et al., 2015; Stiburek et al., 2009, 2005;
Tiranti et al., 1999; Weraarpachai et al., 2009; Williams et al.,
2004). Hence, the assembly pathway appears to progress
through distinct intermediates that are subject to quality control
processes at distinct stages. Despite a physical interaction be-
tween MITRAC7 and COX1, our analyses do not demonstrate
a direct role for MITRAC7 in quality control. However, our ana-
lyses assign a chaperone-like function to MITRAC7, it stabilizes
COX1 in the assembly process. It is likely that MITRAC-mediated
stabilization of COX1 is required until additional subunits engage
with the COX1-containing intermediate.
We show that MITRAC7 acts at a stage of the assembly pro-
cess at which first nuclear-encoded subunits of the cytochrome
c oxidase have already been integrated into the maturing COX1-
containing MITRAC complex. Overexpression of MITRAC7 stallsCell Rethe COX1 assembly process and leads to the accumulation of a
slower migrating form of MITRAC. Moreover, when MITRAC7-
containing complexes are isolated, they contain COX4-1. The
knockdown of MITRAC7 did not affect the association of
TIM21 with newly synthesized mitochondria-encoded proteins,
which are present in early assembly intermediates of complexes
I and IV (Mick et al., 2012). Upon knock down of TIM21, COX4-1,
or COX6C, the association between newly synthesized COX1
and MITRAC7 is drastically reduced, while the interaction be-
tweenCOX1 and the early actingMITRAC12 remains unaffected.
Hence, we conclude that MITRAC7 is dispensable for early
stages of COX1 assembly, but acts after the association of
COX1 with COX4-1 and COX6C. At this point, MITRAC7 is
required for progression of the assembly process. Once
MITRAC7 function is lacking, assembly cannot continue and
the accumulating transient assembly intermediate is obviously
recognized by a yet undefined mechanism and concomitantly
removed. Under conditions of MITRAC7 over abundance,
MITRAC7 associates with COX1 and apparently protects the
COX1-containing assembly intermediate in agreement with a
stabilizing chaperone-like function.
In summary, our analyses suggest that two distinct check-
points during the assembly process of the cytochrome c oxidase
exist. The presence of control elements, that evaluate the abun-
dance of intermediates, initiate processes to adjust the balance
within the cytochrome c oxidase assembly process, or that sta-
bilize transient intermediates, are essential to monitor and coor-
dinate formation of enzyme complexes derived from subunits of
dual genetic origin. In this process, MITRAC7 represents a chap-
erone-like assembly factor that stabilizes COX1 in a late MITRAC
form, timing the catch to receive additional subunits.EXPERIMENTAL PROCEDURES
Cell Culture
HEK293-Flp-InTM T-RExTM 293 or HEK293T were cultured in DMEM, supple-
mented with 10% (volume/volume [v/v]) fetal bovine serum (FBS) (Biochrom),
2 mM L-glutamine and 50 mg/ml uridine at 37C under a 5% CO2 humidified
atmosphere. A HEK293T cell line, with inducible expression of the C-terminal
FLAG-tagged MITRAC7 (NM_001145432.1) protein, was generated as
described previously (Mick et al., 2012).
Immunofluorescence
Immortalized human osteosarcoma cells (U2OS) were incubated with Mito-
Tracker red under cell culture conditions for 5 min. The cells were fixed with
4% paraformaldehyde (PFA) for 20 min at 37C and permeabilized with
0.2% Triton. The cells were blocked with 1% BSA and incubated with anti-
FLAG antibodies at room temperature (RT). The secondary antibody (anti-
mouse M488) was applied for 1 hr at RT. Light microscopy was performed
using a Leica SP5 confocal microscope (Leica Microsystems) equipped with
a 1.40 NA oil immersion objective (Leica HCX PL APO lambda blue 633
/1.40–0.60 Oil UV). The image stacks were taken and maximum projections
of the stacks were generated.
siRNA Constructs and Transfection
The following sequences and concentrations were used: TIM21 (50-CCCAG
GAAGUGGUGAAUAU-30; 8.25 nM), MITRAC12 (50-CGCAGUUGUUACGAG
GUUA-30, 33 nM), MITRAC7 (50-GAAGGAACAAGCUAUAAAU-30, 33 nM),
COX4-1 (50- GUCGAGUUGUAUCGCAUUA-30, 33 nM), and COX6C (50-GG
CUGGUAUCUUUCAGAGU-30, 33 nM). Approximately 2.5 3 105 cells were
seeded in a 25 cm2 flask and transfected as described previously (Ovcharenkoports 12, 1644–1655, September 8, 2015 ª2015 The Authors 1653
et al., 2005) using LipofectamineTM RNAiMAX (Invitrogen). The cells were
cultured for 72 hr prior to analyses.
Protein Localization and Protease Protection Assays
Carbonate extraction andmitochondrial swelling experiments were essentially
performed as previously described (Mick et al., 2012). Briefly, isolated mito-
chondria were suspended in 10 mM 3-(N-morpholino)propanesulfonic acid
(MOPS) (pH7.2), 50 mM NaCl containing either 1% Triton X-100 or 0.1 M car-
bonate at pH 10.5 or 11.8. Samples were centrifuged at 55,000 rpm and 4C
for 45 min in a TLA-55 rotor (Beckman Coulter). To analyze submitochondrial
localization, samples were either suspended in SEM buffer (250 mM sucrose,
1mMEDTA, and 10mMMOPS [pH 7.2]), to osmotically stabilizemitochondria,
or in EM buffer (1 mM EDTA, and 10 mM MOPS [pH 7.2]), to rupture the outer
mitochondrial membrane, followed by the addition of proteinase K (PK). As a
positive control, mitochondria were lysedwith 1%Triton X-100 in the presence
of PK. The reaction was stopped after 10 min by addition of PMSF (2 mM final
concentration), followed by trichloroacetic acid (TCA) precipitation.
In Vitro Protein Import into Isolated Mitochondria
Protein coding sequences were cloned downstream of the SP6 promoter into
pGEM3Z (Promega) or RNA was synthesized, using the mMESSAGE
mMACHINE SP6 Kit and MEGAclear Kit (Ambion) using SP6 promotor-con-
taining PCR products as templates. TNT SP6 Quick Coupled Transcription/
Translation system (Promega) or alternatively Flexi Rabbit Reticulocyte Lysate
System (Promega) were used to synthesize in vitro [35S]methionine-labeled
precursor proteins. In vitro protein import into isolated human mitochondria
was performed as described previously (Lazarou et al., 2009). Samples were
separated either by SDS- or BN-PAGE and radiolabeled proteins were visual-
ized using Storage Phosphor Screens and a Storm 820 scanner from GE
Healthcare. For quantifications ImageQuant TL software was used (GE
Healthcare).
In Vivo [35S]methionine Labeling of Mitochondrial Translation
Products
Labeling was performed in 25 cm2 flasks as described previously (Chomyn,
1996). To inhibit cytosolic translation, cells were either treated with
100 mg/ml emetine (Invitrogen) during pulse experiments, or with 100 mg/ml
anisomycin in pulse chase experiments. Mitochondrial translation products
were labeled with 0.2 mCi/ml [35S]methionine for 1 hr. In chase experiments,
the radioactive medium was removed, 10 ml fresh growth medium added, fol-
lowed by incubation at 37C under 5% CO2 atmosphere for the indicated time
points. The cells were recovered in 1 mM EDTA/PBS. The samples were
further analyzed either by SDS- or BN-PAGE.
BN-PAGE Analysis
BN-PAGE analysis was performed as previously described (Mick et al., 2012).
Briefly, mitochondrial protein-complexes were extracted by lysing mitochon-
dria in 1% digitonin, 20 mM Tris-HCl (pH 7.4), 0.1 mM EDTA, 50 mM NaCl,
10% (weight/volume [w/v]) glycerol, and 1 mM PMSF buffer. Non-solubilized
material was removed by centrifugation (20,000 xg, 15 min, 4C). Mitochon-
drial complexes were separated on 4%–13% or 4%–14% polyacrylamide
gradient gels as described previously (Wittig et al., 2006). In gel activity, assays
were performed according to published procedures (Wittig et al., 2006).
Cytochrome c Oxidase Activity and Quantitation Assay
Complex IV Human Specific Activity Microplate Assay Kit (Mitosciences,
Abcam) was used to determine specific activity and relative amount of cyto-
chrome c oxidase according to the manufacturer’s instructions. Total 15 mg
of cell lysate was loaded per well. The oxidization of cytochrome c and the
decrease of absorbance at 550 nm were measured for cytochrome c oxidase
activity. To determine the relative COX amount, the increase of absorbance at
405 nm after incubation with a specific cytochrome c oxidase antibody, con-
jugated to alkaline phosphatase, was measured.
Affinity Purification Procedures
Isolated mitochondria or whole cell extracts (0.5–2 mg) were resuspended
(final 1 mg/ml) in lysis-buffer (20 mM Tris-HCl [pH 7.4], 150 mM NaCl,1654 Cell Reports 12, 1644–1655, September 8, 2015 ª2015 The Au0.1 mM EDTA, 10% (w/v) glycerol, 1 mM PMSF, and 1% (w/v) digitonin) and
incubated for 30 min at 4C under mild agitation. To remove non-solubilized
material, the lysate was centrifuged at 20,000 xg, 4C for 15min. Supernatants
were incubated with anti-FLAG-agarose (Sigma-Aldrich) or ProteinA-Sephar-
ose (GE Healthcare) conjugated with specific or control antibodies. Affinity
resins were washed prior to elution with FLAG-peptides or by pH shift.
In Vitro Crosslinking
MITRAC7FLAG containing mitochondria (500 mg) were incubated with BS2-d0
crosslinker (final 2.5 mM) in crosslinking buffer (20 mM HEPES [pH 7.4] and
100 mM NaCl) for 30 min on ice. The crosslinking reaction was quenched by
the addition of glycine (pH 8.0) to a final concentration of 250 mM and incuba-
tion on ice for 15 min. Mitochondria were pelleted, resuspended in 200 ml lysis
buffer (20 mM Tris-HCl [pH 7.4], 150 mM NaCl, 0.1 mM EDTA, 10% [w/v] glyc-
erol, 1 mM PMSF; 1% [w/v] SDS, and 1% Triton X-100), incubated at RT for
30 min, and 1.2 ml lysis buffer without SDS and Triton X-100 was added. To
remove non-solubilized material, the lysate was centrifuged at 20,000 xg,
4C for 15 min and immunoprecipitation was performed as described above.
Miscellaneous
Standard methods were used for SDS-PAGE and western-blotting of proteins
to PVDF membranes (Millipore). Primary antibodies were raised in rabbits and
HRP-coupled secondary antibodies applied to antigen-antibody complexes
and detected by enhanced chemiluminescence on X-ray films.
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